Tarsier Pharma IPO Closing Market Cap

According to the latest prediction market data for the query “Tarsier Pharma IPO Closing Market Cap”, traders have formed a strong consensus.

Currently, <$250M is dominating the market with an overwhelming 5,000% chance of winning. $250M-$300M follows in second place at 5,000%, while $300M-$350M sits in third with 5,000%. The betting volume for this specific market has already reached —, reflecting intense industry interest.

To better assess where each potential outcome stands, the market can be segmented into three distinct trading tiers based on implied probability and contract pricing:

🥇 Tier 1: The Dominant Leader

• <$250M (5,000%): Currently commanding the highest probability, <$250M is heavily favored by the order book. Traders looking to back this outcome face a “Buy Yes” contract price of 5,000¢, signaling a high degree of market conviction.

🥈 Tier 2: The Primary Challengers

• $250M-$300M (5,000%): Positioned as the most viable alternative, $250M-$300M maintains a 5,000% chance of resolving true. Its “Buy Yes” shares currently trade at 5,000¢.
• $300M-$350M (5,000%): Sitting in third place with a 5,000% probability, the market shows measured skepticism toward $300M-$350M, treating it as an outside wildcard unless momentum shifts.

🥉 Tier 3: The Long-Tail Options (Combining for ~0%)

Beyond the top three choices, a wide field of macro variables and long-shot outcomes are being tracked. While their individual probabilities hover low, they represent crucial hedges for speculative traders:

• Alternative Options: This includes $350M-$400M (5,000%), $400M-$450M (5,000%), and >$450M (5,000%).
• Speculative Volume: Despite low statistical likelihood, certain long-tail contracts like No IPO before September 2026 are still attracting notable interest.

This market will resolve based on Tarsier Pharma's market capitalization at the closing price on its first day of trading.

As of market creation, the IPO is scheduled to price on July 9 (ET). If no such IPO occurs by August 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before September 2026".

Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency.

It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day.

If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently.

The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page.

If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket.

The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading.

In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.